中文名稱(chēng):pRL-CMV 載體 | 英文名稱(chēng):pRL-CMV |
保存條件: 常溫運(yùn)輸 | 純度規(guī)格: 99% |
產(chǎn)品類(lèi)別: 質(zhì)粒/載體 |
The pRL-CMV Vector(a,b,c) (Figure 1) is intended for use as an internal control reporter and may be used in combination with any experimental reporter vector to co-transfect mammalian cells. All of Promega’s pRL Reporter Vectors contain a cDNA (Rluc)(a) encoding Renilla luciferase, which was originally cloned from the marine organism Renilla reniformis (sea pansy; 1). As described below, the Renilla luciferase cDNA contained within the pRL Vectors has been modified slightly to provide greater utility.
The pRL-CMV Vector contains the CMV(b) enhancer and early promoter elements to provide high-level expression of Renilla luciferase in co-transfected mammalian cells. Renilla luciferase is a 36kDa monomeric protein that does not require posttranslational modification for activity (2). Therefore, like firefly luciferase, the enzyme may function as a genetic reporter immediately following translation. For information about the use of this plasmid in conjunction with a reporter vector containing the firefly luciferase gene, refer to the Dual-Luciferase® Reporter Assay System(c,d,e) Technical Manual (#TM040).
To avoid DNA methylation, all pRL Vectors are isolated from a dam-/dcm- E. coli K host strain. Therefore, initial propagation of the pRL-CMV Vector should be conducted in an appropriate E. coli host strain lacking endogenous restriction endonuclease activity (e.g., JM109).
特別提示:本公司的所有產(chǎn)品僅可用于科研實(shí)驗(yàn),嚴(yán)禁用于臨床醫(yī)療及其他非科研用途!
成立日期 | 2016-08-08 (9年) | 注冊(cè)資本 | 100萬(wàn)元整 |
員工人數(shù) | 1-10人 | 年?duì)I業(yè)額 | ¥ 100萬(wàn)以內(nèi) |
主營(yíng)行業(yè) | 生物化工,有機(jī)原料,化學(xué)試劑,醫(yī)藥原料,技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,試劑,定制,服務(wù) |
產(chǎn)品名稱(chēng) | 價(jià)格 | 公司名稱(chēng) | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥1280 |
VIP1年
|
湖北艾普蒂生物工程有限公司
|
2025-02-08 | |
¥888 |
VIP6年
|
上??道噬锟萍加邢薰?/div>
|
2025-02-08 | |
¥2896 |
VIP4年
|
上海博爾森生物科技有限公司
|
2025-02-08 |